Practice profile of Indian gynaecologists on the use of micronized progesterone and dydrogesterone in pregnancy and assisted reproductive technology cycles: progress survey [PDF]
Background: Though progesterone supplements are prescribed for progesterone deficiency in pregnant and infertile women, there is ambiguity on the different forms of progesterone supplements prescribed in various conditions, duration, dosing regimen, etc.
Deshmukh, Priyanka+4 more
core +4 more sources
Cervical and Vaginal Microbiomes in Early Miscarriages and Ongoing Pregnancy with and without Dydrogesterone Usage. [PDF]
Emerging evidence suggests that the reproductive tract microbiota is a key modulator of local inflammatory and immune pathways throughout pregnancy and may subsequently impact pregnancy outcomes.
Gryaznova M+6 more
europepmc +4 more sources
The Role of Dydrogesterone in the Management of Luteal Phase Defect: A Comprehensive Review. [PDF]
The luteal phase of the menstrual cycle is a pivotal period characterized by hormonal intricacies that lay the foundation for successful embryo implantation and early pregnancy development.
Muneeba S, Acharya N, Mohammad S.
europepmc +4 more sources
Dydrogesterone use in recurrent pregnancy loss and luteal phase insufficiency: a knowledge, attitude, and practice survey amongst Indian obstetricians and gynaecologists [PDF]
Background: Oral dydrogesterone is effective in treating reproductive disorders such as recurrent pregnancy loss (RPL) and is a better option than progesterone for luteal phase support (LPS) after in-vitro fertilization (IVF).
Bapat, Kawita+16 more
core +4 more sources
Absence of evidence is not evidence of absence for first trimester dydrogesterone-induced birth defects. [PDF]
Quadros R, Puppalwar G, Mane A, Mehta S.
europepmc +4 more sources
The role of dydrogesterone in habitual miscarriage
Habitual miscarriage is a fairly common complication of early pregnancy. In the opinion of most authors, the term habitual miscarriage is used to describe a loss of two or more pregnancies during the first 22 weeks of pregnancy. Issues of terminology and management continue to be relevant and debatable in medical professional communities and need ...
E. S. Polushkina, R. G. Shmakov
openaire +5 more sources
Oral dydrogesterone as an adjunctive therapy in the management of preterm labor: a randomized, double blinded, placebo‐controlled trial [PDF]
Background Preterm birth is a major challenge in obstetric and perinatal care. It is the leading cause of neonatal death. The primary aim of this study was to evaluate the efficacy of oral dydrogesterone on latency period in managing preterm labor.
Suparudeewan Thongchan, Vorapong Phupong
doaj +2 more sources
Dydrogesterone in the treatment of endometriosis: evidence mapping and meta-analysis [PDF]
Abstract Purpose Endometriosis is a common, chronic gynecological disease that affects women’s fertility potential. Dydrogesterone is an effective and safe drug that is under-utilized due to limited clinical research.
Chao Peng, Yan Huang, Yingfang Zhou
openaire +4 more sources
Purpose This study aimed to compare the efficacies of Femoston and Dydrogesterone therapy in patients with incomplete abortions.Methods Patients with incomplete abortions were included if they preferred medication over surgical intervention.
Xueyao Huang+4 more
doaj +2 more sources
Dydrogesterone update: insights on its therapeutic applications [PDF]
Progesterone deficiency is commonly implicated as an important etiology in pregnancy complications like threatened miscarriage, luteal phase defect (LPD), recurrent pregnancy loss (RPL), etc.
Luniya, Sharul Sajjan+2 more
core +3 more sources